An improved understanding of cell immortalization and its manifestation in clinical tumors could facilitate novel therapeutic approaches. However, only rare tumor cells, which maintain telomerase expression in vitro, immortalize spontaneously. By expression-profiling analyses of limited-life primary breast tumor cultures pre-and posthTERT transduction, and spontaneously immortalized breast cancer cell lines, we identified a common signature characteristic of tumor cell immortalization. A predominant feature of this immortalization signature (ImmSig) was the significant overexpression of oxidoreductase genes. In contrast to epithelial cells derived from low histologic grade primary tumors, which required hTERT transduction for the acquisition of ImmSig, spontaneously immortalizing high-grade tumor cultures displayed similar molecular changes independent of exogenous hTERT. Silencing the hTERT gene reversed ImmSig expression, increased cellular reactive oxygen species levels, altered mitochondrial membrane potential and induced apoptotic and proliferation changes in immortalized cells. In clinical breast cancer samples, cell-proliferation-pathway genes were significantly associated with ImmSig. In these cases, ImmSig expression itself was inversely correlated with patient survival (P ¼ 0), and was particularly relevant to the outcome of estrogen receptor-positive tumors. Our data support the notion that ImmSig assists in surmounting normal barriers related to oxidative and replicative stress response. Targeting a subset of aggressive breast cancers by reversing ImmSig components could be a practical therapeutic strategy.
Introduction
Cell immortalization is a hallmark of cancer, induced by physical, chemical and biological agents. An in-depth understanding of the molecular pathways leading to this phenotype, and the variability inherent in its acquisition, could improve clinical cancer management. Reactivation of telomerase for maintaining the telomeric ends of chromosomes is an essential prerequisite towards the immortalization of proliferating tumor cells (Counter et al., 1992) . Conversely, the absence of telomerase activity in model systems results in replicative senescence (reviewed in Ben-Porath and Weinberg, 2005) , which is reversed by ectopic expression of the catalytic subunit of telomerase, hTERT (Bodnar et al., 1998) . In addition to the classical role of telomerase in telomere elongation, evidence suggests that it enhances cell survival under conditions of cellular stress by regulating the expression of proliferation and apoptosis-inducing genes (Xiang et al., 2002; Zhang et al., 2003; Dudognon et al., 2004) , suppresses cell differentiation (Wang et al., 2005) , and contributes to the overall maintenance of chromatin and DNA-damage response (Masutomi et al., 2005) . hTERT-induced immortalization of normal human mammary epithelial cells (HMEC) confers resistance to TGF-b growth inhibition (Stampfer et al., 2001) , and reduction in growth factor requirements (Smith et al., 2003) .
Our previous work with primary breast tumor cell culture demonstrated that immortality was not a constitutive trait of all malignant cells in vitro (Dairkee et al., 2004) . Molecular changes underlying finite mitotic life included high transcript levels of TGFb, and other negative growth regulating genes accompanied by the extinction of telomerase expression and catalytic activity. Our principal component analyses based on gene expression patterns demonstrated that primary tumor cultures lacking hTERT clustered apart from short-term HMEC, as well as from those rare primary tumor cultures that immortalized spontaneously and displayed hTERT expression comparable to that of established cancer cell lines. Consistent with the reported literature (Kurz et al., 2004) , it appears that high oxygen levels, characteristic of routine culture conditions, generate oxidative stress resulting in telomerase extinction and replicative senescence in most primary tumor cultures. Thus, we reasoned that hTERT transduction might rescue such tumor cell cultures from a suboptimal microenvironment, and confer immortality in a single step. We have identified an immortalization signature (ImmSig) in tumor cell cultures, and demonstrated its manifestation in tumor tissue. Instead of routine proliferation changes associated with immortalization, we found that ImmSig was largely composed of genes promoting cellular oxidoreductase activity. These findings suggest that although continuous cell proliferation may portray the final effect of immortalization, ImmSig identifies the symptomatic cellular changes leading to it. The application of the unique ImmSig profile to a clinical breast cancer database revealed patient subsets that might benefit from anti-telomerase therapies and/or redox modulators in conjunction with other cancer treatments.
Results
hTERT induced the immortalization of primary breast tumor cultures Breast tumor tissue propagated by conventional approaches generally results in cultures biologically resembling normal rather than malignant epithelial cells. We previously implemented novel methods for tissue dissociation and processing to enrich and selectively expand tumor cells. A major advantage of our modified protocols is that they allow invasive tumor cells in the tissue to be fractionated, and non-malignant epithelium confined by an intact basement membrane to be excluded. Tumor cultures resulting from such methodological improvements closely resemble the original tumor tissue in characteristics, such as the presence of aneuploidy, clonal loss of heterozygosity, clonal p53 mutations, ERBB2 amplification and overexpression, and in global gene expression patterns as measured by cDNA microarrays (Dairkee et al., 1995 (Dairkee et al., , 1997 (Dairkee et al., , 2004 Li et al., 1998) . In a comprehensive quantitative real-time reverse transcription-polymerase chain reaction (QPCR) analysis (Figure 1a ) of tumor cells cultured from primary breast cancers of varying degrees of clinical aggressiveness, we demonstrate here that high transcript levels of hTERT, and hTERC (the RNA component of telomerase), were maintained only by high histologic grade-derived tumor cells, which gave rise to spontaneously immortalizing (SI) cultures (3/3). Epithelial cultures of low-and intermediate-grade tumors, where expression of both genes was below the baseline level of non-malignant epithelium, displayed limited proliferation (21/21). These were designated as non-spontaneously immortalizing (NSI) tumors.
To induce cell immortality in NSI tumor cultures, we considered that since they already harbor multiple changes associated with malignant transformation (references cited above), the abrogation of senescence barriers, a characteristic of normal HMEC in vitro, might not be required. Indeed, we observed that the introduction of hTERT alone was sufficient to immortalize cells isolated from NSI tumors (three grade I, five grade II). hTERT-transduced tumor cells were compared with vector only controls for the ability to proliferate continuously. While NSI control cells displayed proliferation to p7 passages (B15 population doublings), matched hTERT-transduced cells currently average 60 passages (B125 population doublings, Supplementary Table 1 ). Whereas hTERC transcript levels were relatively unchanged in transduced cultures, hTERT expression was up to 4000-fold greater than those of control cultures (Figure 1b ) resulting in robust cell growth (Figure 1c ). This indicated that for the emergence of cell immortality in NSI cultures, (a) endogenous hTERC expression adequately supported the experimentally increased telomerase activity (data not shown), and/or (b) hTERT overexpression was largely independent of its DNA synthesis function wherein hTERC served as its template for the addition of new telomeric repeats.
Global gene expression changes associated with immortalization of primary breast tumor cultures Nine isogenic sets of primary tumor cultures pre-and post-hTERT-transduction were assayed using 42 000 feature cDNA microarrays. Primary tumor cell cultures without exogenous hTERT were designated as tumor control (TC), and those transduced with hTERT, as tumor transduced (TT). Significance analysis of microarray (SAM)-based comparisons were made between TC and TT cultures of NSI cases. At a median false discovery rate (FDR) of 6.70%, 5164 Unigene IDs deemed significant by SAM were selected (3027 up, and 2137 down genes in TT cultures) and applied towards Gene Ontology (GO) analysis (Boyle et al., 2004) to define the underlying biology. Additionally, corresponding to the minimum FDR (median ¼ 0.08%), 597 genes (427 up, and 170 down genes in TT cultures) were retrieved and used to compute a centroid, designated as the ImmSig. Genes representing this signature were concordantly induced or repressed in hTERT-immortalized primary cultures of low-and intermediate-grade tumors (Figure 2a ). hTERT showed the highest level of expression (>100-fold) as expected for an experimentally transduced gene. Other ImmSig genes were upregulated up to sixfold, or downregulated down to 10-fold (Supplementary Dataset 1) . GO annotation analysis of upregulated ImmSig genes confirmed that in response to immortalization cues, induction of genes occurred in pathways encompassing multiple mitochondrial functions, in particular, oxidoreductase activity (COX5A, CBR3, OGDH, multiple isoforms of NADH dehydrogenase (ubiquinone) 1 alpha and beta subcomplexes, NQO2), catalytic activity (PCYT2, ATP5G2, UQCRC, FDFT1), RNA binding (DCP2, RPS4X, KHSRP), and as structural constituents of the ribosome (RPL36, RPL30, MRPL48, RPS5, MRPS5) (Table 1  and Supplementary Table 2 ).
Synergistic expression of ImmSig in hTERTimmortalized and spontaneously immortalized primary tumor cultures
Compared with TC cultures of NSI tumors, correlation to ImmSig was higher for early passage TT cultures (2 0 -6 0 , designated as TT1), and highest in late-passage populations (15 0 -35 0 , designated as TT2) ( Figure 2b , top panel). We then determined whether ImmSig expression was displayed by (a) SI cases among our patient samples, and (b) breast cancer cell lines routinely used in the field, which are by definition, spontaneously immortalized. Twenty-nine TC and TT samples from cultures representing NSI and SI cases, including early and late passages of a sample for which a matched TC was not available (CCdl067TT1 and CCdl067TT2), were ranked by their correlation to the ImmSig. Notably, TC The unexpected induction of telomere-independent pathways in immortalized tumor cultures prompted us to spot-test the microarray data using RNA interference. Transfection with hTERT siRNA resulted in >60% inhibition of hTERT mRNA expression (Figure 3a Figure 3b ) and a detectable reduction in mitochondrial membrane potential (Figure 3c ). hTERT knockdown caused a significant induction of apoptosis ( Figure 3d ) and >2-fold reduction in cell density relative to non-targeting siRNA in immortalized primary tumor cultures (Figure 3e ). These cellular responses were accompanied by a marked reduction (up to 80%) in transcript levels of ImmSig genes in various functional categories as measured by QPCR (Figure 3f ). Together, these findings confirm that hTERT expression was critical for the survival and growth of both SI and NSI tumor cultures, and validate its association with a spectrum of ImmSig genes related to the dissipation of oxidative stress.
ImmSig expression and clinical outcome in breast cancer
To reveal additional in vivo biology associated with the ImmSig phenotype, we used microarray data on tumors derived from primary breast cancer patients treated at the Nederlands Kanker Instituut (NKI). We first sought to identify genes, not part of ImmSig but whose expression levels were highly associated with the ImmSig phenotype (Figure 4 ). Enriched GO terms for ImmSig-associated genes in the 95th percentile (highly correlated) predominantly displayed pathways of: macromolecule metabolism (GZMB, HIST1H1B, CENPA, RRM2, ORC6L, UBE2C), and cell cycle (BIRC5, KIFC1, ESPL1, CCNB1, EXO1, PTTG1, AURKB, BUB1, CKS2). Pathways associated with the bottom 5th percentile (highly anticorrelated) included phosphate transport (COL10A1, COL6A3, COL12A1), and extra cellular matrix (MATN3, LUM, COL14A1). Intriguingly, in contrast to the distinctive oxidative changes identified by ImmSig itself, ImmSig-associated genes mostly reflected the proliferation-related aberrations previously reported in immortal cell lines and aggressive tumors (Table 1) . Next, we ranked NKI tumors by their correlation to ImmSig to determine a pattern of association with known breast cancer molecular subtypes (Perou et al., 2000; Sorlie et al., 2001 Sorlie et al., , 2003 . Among estrogen receptor (ER)-negative tumors, the ERBB2 overexpressing subtype was relatively uncorrelated, while basal tumors showed higher ImmSig correlation. Among ER-positive tumors, the luminal A subtype displayed lower ImmSig correlation in comparison to the luminal B subtype, generally known to represent highly proliferative tumors (Figure 4) .
Finally, we determined whether correlation to ImmSig for tumors in the NKI dataset was indicative of overall survival and time to metastasis by the Cox proportional hazards model. For both clinical endpoints, patients in the top tertile of ImmSig correlations were found to be associated with worse outcome for diseasefree survival and death (Po0.001, Figure 5 , top panels). When patients were subdivided by correlation to the ImmSig in conjunction with the ER status, higher ImmSig correlation was found to be significantly associated with poor outcome specifically in ER-positive patients (Po0.05, Figure 5 , bottom panels). ImmSig expression was not predictive of prognosis in ERnegative tumors (Supplementary Figure 1) . Importantly, the hTERT gene alone was not prognosticative in this Figure 2 ) in contrast to a reported association (Elkak et al., 2005) . In the light of a recent study that has questioned the specificity of hTERT antibodies (Wu et al., 2006) , data obtained by immunostaining of tumor tissue requires further verification.
dataset (Supplementary
In ER-positive tumors, only top ImmSig tertile and high histologic grade maintained significance as measured by multivariate analysis of known prognostic factors (P ¼ 0.01, and P ¼ 0.05, respectively, Table 2 ). In conclusion, aside from its role in the immortalization of primary breast tumor cultures, ImmSig-based separation of patient outcome provides strong evidence that this in vitro derived signature captures an in vivo phenotype portraying relevance to clinical disease.
Discussion
We have shown that comparison of multiple isogenic sets of finite mitotic life and hTERT-immortalized primary breast tumor cells has provided further molecular understanding of cancer cell immortalization, a key hallmark of malignancy. While cell cultures derived from high histologic grade tumors adapted readily to in vitro environmental conditions and continued to proliferate, resulting in spontaneously immortalized lines, low-and intermediate-grade tumor cells exhibited telomerase repression leading to a finite mitotic life. These events have a direct bearing on the fact that the latter class of tumors remains unrepresented among currently available cancer cell lines, and (van de Vijver et al., 2002; van't Veer et al., 2002; Chang et al., 2005; Sotiriou et al., 2006) , ImmSig is distinct. Like ImmSig, the fibroblastbased common serum response signature (Chang et al., 2005) is biologically derived from cell culture studies, yet elements common to the two signatures, related to cell cycle and proliferation, are represented not in ImmSig itself but as ImmSig-associated genes. This is likely due to the fact that fibroblasts are strikingly more resistant to stress than other cell types (Michiels et al., 1990; Serrano and Blasco, 2001 ). While ImmSig-based outcome is more relevant to ER-positive breast tumors, other gene lists designed specifically for predicting the outcome of ER-positive tumors (Ma et al., 2004; Paik et al., 2004) , could serve as better prognostic indicators. In our view, ImmSig might be more effective in improving patient outcome by evoking functional response to therapeutics highlighted by this signature, such as anti-telomerase and antioxidant approaches.
As yet, the molecular and clinical consequences of oxidative stress in the tumor microenvironment are not well understood. Response to oxidative stress is known to be variable since, in some systems, it results in apoptosis resistant cell populations (Shami et al., 1998) , while in others it promotes a senescence phenotype accompanied by upregulation of the p53 dependent, p21 gene (Chen et al., 1998) . Intuitively, it may be surmised that in vivo, oxidative stress plays a key role in the selection of p53-deficient clones (Storz, 2005) , which are generally ER-negative (Sorlie et al., 2003) . Our study sheds new light on the link between oxidative stress and aggressiveness in ER-positive tumors. Overexpression of a significant number of oxidoreductase activity genes observed here in ER-positive, highly proliferative luminal tumors implicates that oxidative stress may be intrinsic to this subtype. Our observations are synergistic with the known effects of oxidative stress in impairing ER functions related to DNA binding and transactivation (Liang et al., 1998) . Thus, it seems plausible that high-ImmSig, ER-positive tumors are functionally analogous to estrogen-independent, ERnegative tumors and are likely to show less sensitivity to conventional hormonal therapies. Indeed, conversion to a tamoxifen-resistant phenotype is associated with oxidative stress in the ER-positive MCF-7 cell line (Schiff et al., 2000) . Future work with ImmSig genes could provide additional approaches for the management of tumors resistant to anti-estrogen therapy.
At this time it has not been determined whether cultures derived from all tumors with a higher ImmSig correlation immortalize spontaneously. Considering the rarity of spontaneously immortalized cell lines, it is conceivable that clinical samples only at the uppermost end of the ImmSig-correlated tertile may be indicative of this phenotype. ImmSig pathways induced upon the acquisition of immortalization in vitro support the view that at a biological level, this phenotype represents the proclivity to (a) overcome growth arresting oxidative damage, and (b) sustain cell survival and growth. The subset of high ImmSig breast tumors may well be one that harbors a greater aptitude to prevail under adverse microenvironmental conditions including resistance to clinical interventions such as treatment with radiation and DNA-damaging drugs. Foreseeably, the addition of redox modulators and telomerase inhibitors to the therapeutic regimen of high-ImmSig cases could improve disease outcome.
Materials and methods
An expanded version of this section is provided as a Supplementary methods file.
Tumor cell culture and hTERT transduction Fresh primary breast tumor samples and reduction mammoplasty tissues, collected under IRB-approved guidelines, were propagated as described previously (Dairkee et al., 1997; Li et al., 1998) . For retroviral infection of primary tumor cultures at passage 3-4, supernatant from PA317 packaging cells infected with pBabePuro containing hTERT (kindly provided by Dr Elizabeth Blackburn, UCSF) or control vector was used. Infection efficiency was approximately 10%. Control uninfected cultures were completely non-viable after 7 days of treatment with 1.5 mg/ml puromycin (Sigma, St Louis, MO, USA). After an additional 7 days of drug selection, hTERT overexpressing stably infected tumor cell populations were continuously expanded and passaged as mass cultures.
Gene expression and functional assays Total RNA was extracted from subconfluent primary tumor cultures with the RNAeasy Mini kit (Qiagen, Chatsworth, CA, USA). cDNA was synthesized and analyzed as reported previously (Dairkee et al., 2004) using QPCR in conjunction with an Applied Biosystems 5700 Sequence Detection System (Foster City, CA, USA).
For hTERT gene silencing, pre-annealed siRNA duplex was purchased from Dharmacon Research (Lafayette, CO, USA). siCONTROL non-targeting siRNA#1 served to evaluate offtarget effects of siRNA transfection. PCR primers for ImmSig genes are listed in Supplementary Table 3 . Additional effects of hTERT siRNA were evaluated using standard methods in the following functional assays: growth rate, apoptotic fraction, generation of ROS, and mitochondrial depolarization.
Constructing the ImmSig and testing clinical tumor samples
Array data from B42 000 feature cDNA microarrays of NSI tumor cultures was used to compute ImmSig. Two classes of samples, non-transfected TC cultures and TT were compared. Analysis of variance (ANOVA) correction was performed such that the weight of the TT and TC cultures was the same for each patient. Data were then analysed using significance analysis of microarrays (SAM, Tusher et al., 2000) . Corresponding to the minimum FDR of 0.08%, 597 Unigene Clone IDs were used to compute a centroid (mean expression for each gene within a class) for each class, TT and TC. The centroid for the TT class (the cultures immortalized by hTERT transfection) was denoted as the ImmSig. For measuring relative correlation to ImmSig among primary tumor cultures and cell lines, an ANOVA correction was performed on each dataset, and samples were sorted by their Pearson correlation to ImmSig.
Global expression data in a previously published NKI dataset of 295 Stage I and II breast cancers from women less than 53 years of age (van de Vijver et al., 2002; Chang et al., 2005) were collapsed by UniGene Cluster ID (Build #183), and transformed from log 10 to log 2 .
After gene mean centering, correlation to the ImmSig was computed for each tumor and rather than clustering, tumors were sorted by this correlation. Tumors were then separated into tertiles based on whether their correlation to the ImmSig was greatest or smallest in the cohort. Kaplan-Meier survival curves were computed for overall survival and time to metastasis.
To identify additional genes associated with ImmSig, an ImmSig-correlation vector (ICV) was computed. Genes whose correlation to the ICV was in the 95th percentile (most correlated) or in the 5th percentile (most anti-correlated) were identified and used for analysis of enriched GO terms (Boyle et al., 2004) . To generate a heatmap, tumors were sorted by the ICV, and genes were sorted by their correlation to this vector.
Associations between ImmSig correlation in top or bottom tertiles, and clinical parameters were analyzed by the w 2 -test. P-values from two-sided tests were considered to be significant when o0.05. For multivariate analysis, a Cox proportional hazards model was fit to data from NKI patients characterized by age, tumor size, number of positive nodes and histologic grade.
